Cite
HARVARD Citation
Hsu, A. et al. (2022). CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab. Leukemia & lymphoma. 63 (1), pp. 31-42. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Hsu, A. et al. (2022). CD5 expression in marginal zone lymphoma predicts differential response to rituximab or bendamustine/rituximab. Leukemia & lymphoma. 63 (1), pp. 31-42. [Online].